Page last updated: 2024-08-16

ribavirin and cyclin d1

ribavirin has been researched along with cyclin d1 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Attar-Schneider, O; Drucker, L; Heffez Aizenfeld, R; Lishner, M; Tartakover Matalon, S; Zismanov, V	1
Cai, Y; Lu, C; Makala, L; Wu, D	1
Cui, S; Huang, Y; Li, Z; Mao, X; Wang, G; Xu, C	1

Reviews

1 review(s) available for ribavirin and cyclin d1

Article	Year
Targeting translation: eIF4E as an emerging anticancer drug target. Expert reviews in molecular medicine, 2016, Jan-18, Volume: 18 Topics: Animals; Antineoplastic Agents; Cyclin D1; Epoxy Compounds; Eukaryotic Initiation Factor-4E; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Macrolides; Neoplasms; Oligonucleotides, Antisense; Protein Biosynthesis; Ribavirin; RNA, Small Interfering; Signal Transduction; Sirolimus; Survivin; Thiazoles; Triterpenes; Vascular Endothelial Growth Factor A	2016

Article

Year

Targeting translation: eIF4E as an emerging anticancer drug target.

Expert reviews in molecular medicine, 2016, Jan-18, Volume: 18

Topics: Animals; Antineoplastic Agents; Cyclin D1; Epoxy Compounds; Eukaryotic Initiation Factor-4E; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Macrolides; Neoplasms; Oligonucleotides, Antisense; Protein Biosynthesis; Ribavirin; RNA, Small Interfering; Signal Transduction; Sirolimus; Survivin; Thiazoles; Triterpenes; Vascular Endothelial Growth Factor A

2016

Other Studies

2 other study(ies) available for ribavirin and cyclin d1

Article	Year
Multiple myeloma proteostasis can be targeted via translation initiation factor eIF4E. International journal of oncology, 2015, Volume: 46, Issue:2 Topics: Autophagy; Cell Line, Tumor; Cyclin D1; Eukaryotic Initiation Factor-4E; Gene Expression Regulation, Neoplastic; Humans; Multiple Myeloma; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-myc; Ribavirin; RNA, Small Interfering; Tetraspanins; TOR Serine-Threonine Kinases; Unfolded Protein Response	2015
Targeting eIF4E inhibits growth, survival and angiogenesis in retinoblastoma and enhances efficacy of chemotherapy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 96 Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Endothelial Cells; Eukaryotic Initiation Factor-4E; Gene Expression Regulation, Neoplastic; Humans; Neovascularization, Pathologic; Proto-Oncogene Proteins c-myb; Retinoblastoma; Ribavirin; RNA, Small Interfering; Signal Transduction; Vascular Endothelial Growth Factor A	2017

Article

Year

Multiple myeloma proteostasis can be targeted via translation initiation factor eIF4E.

International journal of oncology, 2015, Volume: 46, Issue:2

Topics: Autophagy; Cell Line, Tumor; Cyclin D1; Eukaryotic Initiation Factor-4E; Gene Expression Regulation, Neoplastic; Humans; Multiple Myeloma; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-myc; Ribavirin; RNA, Small Interfering; Tetraspanins; TOR Serine-Threonine Kinases; Unfolded Protein Response

2015

Targeting eIF4E inhibits growth, survival and angiogenesis in retinoblastoma and enhances efficacy of chemotherapy.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 96

Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Endothelial Cells; Eukaryotic Initiation Factor-4E; Gene Expression Regulation, Neoplastic; Humans; Neovascularization, Pathologic; Proto-Oncogene Proteins c-myb; Retinoblastoma; Ribavirin; RNA, Small Interfering; Signal Transduction; Vascular Endothelial Growth Factor A

2017